13.80
price up icon5.02%   0.66
after-market After Hours: 13.98 0.18 +1.30%
loading

Avita Medical Inc Stock (RCEL) Forecast

The Avita Medical Inc (RCEL) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $12.93, representing a -6.29% decrease from the current price of $13.80. The highest analyst price target is $15.85, and the lowest is $10.02.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RCEL Price Target
Average 8.2602 (-40.14% Downside)
loading

Is Avita Medical Inc (RCEL) A Buy Now?

Oscillators
Name Value Action
RSI(14) 69.59 Neutral
STOCH(9,6) 67.01 Neutral
STOCHRSI(14) 58.45 Neutral
MACD(12,26) 0.7841 Sell
ADX(14) 52.27 Buy
William %R -11.91 Sell
CCI(14) 50.92 Neutral
Buy: 1 Sell: 2 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
13.28
Buy
13.18
Buy
MA20
12.68
Buy
12.65
Buy
MA50
11.09
Buy
10.93
Buy
MA100
7.8099
Buy
8.9475
Buy
MA200
6.0561
Buy
7.1969
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, RCEL could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on RCEL, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 69.59 indicates that RCEL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 67.01 indicates that RCEL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 58.45 indicates that RCEL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 52.27 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 50.92 indicates that RCEL is still overbought but not to an extreme extent.

Long-term RCEL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Avita Medical Inc financial reports and earnings history, Avita Medical Inc (RCEL) stock could reach $6.5513 by 2030, $6.7254 by 2040 and $11.98 by 2050. See the projected annual prices until 2050 of the Avita Medical Inc stock below:

  • Avita Medical Inc (RCEL) is expected to reach an average price of $9.579 in 2035, with a high prediction of $10.14 and a low estimate of $4.9636. This indicates an $-30.59% rise from the last recorded price of $13.80.
  • Avita Medical Inc (RCEL) stock is projected to chart a bullish course in 2040, with an average price target of $5.9045, representing an $-57.21% surge from its current level. The forecast ranges from a conservative $0.3263 to a sky-high $6.7254.
  • Our analysts predict Avita Medical Inc (RCEL) to jump -37.95% by 2045, soaring from $8.5455 to an average price of $8.5628, potentially reaching $10.28. While $8.5455 is the low estimate, the potential upside is significant.
  • Avita Medical Inc (RCEL) stock is expected to climb by 2050, reaching an average of $12.87, a $-6.72% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.98 and $11.32, respectively, highlighting the market's uncertainty.

Avita Medical Inc Stock (RCEL) Year by Year Forecast

Avita Medical Inc Stock (RCEL) Price Forecast for 2026

The predicted value for Avita Medical Inc (RCEL) in 2026 is set at an average of $9.5332. Estimates vary from a peak of $15.85 to a trough of $3.22, indicating an -30.92% surge from the present price of $13.80.
Month Average Low High Change from today's price
November, 2026 $10.10 $10.02 $15.85 -26.84%
December, 2026 $8.2086 $7.6886 $10.36 -40.52%

Avita Medical Inc Stock (RCEL) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Avita Medical Inc (RCEL) is $4.6949, with a high forecast of $8.815 and a low forecast of $0.5747. This indicates an -65.98% decrease from the last price of $13.80.
Month Average Low High Change from today's price
January, 2027 $6.3714 $6.0514 $8.815 -53.83%
February, 2027 $5.2041 $4.8377 $6.6245 -62.29%
March, 2027 $5.82 $4.1936 $7.05 -57.83%
April, 2027 $4.5427 $2.8164 $5.7832 -67.08%
May, 2027 $2.1786 $2.0486 $5.1291 -84.21%
June, 2027 $1.7814 $1.145 $2.7518 -87.09%
July, 2027 $0.7041 $0.6741 $2.0909 -94.90%
August, 2027 $1.65 $0.7073 $2.2173 -88.04%
September, 2027 $3.3727 $1.4764 $4.2527 -75.56%
October, 2027 $2.3254 $2.1454 $3.3559 -83.15%
November, 2027 $0.9714 $0.9614 $2.9518 -92.96%
December, 2027 $1.0641 $0.5747 $1.3409 -92.29%

Avita Medical Inc Stock (RCEL) Price Forecast for 2028

In 2028, Avita Medical Inc (RCEL) is projected to reach an average price of $9.4195, with a high projection of $18.01 and a low estimate of $0.8273. This indicates an -31.74% fall from the last price of $13.80.
Month Average Low High Change from today's price
January, 2028 $2.84 $0.8273 $3.7936 -79.42%
February, 2028 $2.9627 $2.4863 $3.8095 -78.53%
March, 2028 $4.8454 $2.5291 $5.3454 -64.89%
April, 2028 $5.2982 $4.2786 $6.1182 -61.61%
May, 2028 $9.5341 $5.1145 $10.99 -30.91%
June, 2028 $11.20 $8.7073 $11.21 -18.86%
July, 2028 $8.3827 $7.8827 $13.16 -39.26%
August, 2028 $9.9554 $6.7991 $10.15 -27.86%
September, 2028 $13.31 $9.5886 $14.14 -3.56%
October, 2028 $16.56 $11.17 $18.01 +20.03%
November, 2028 $12.27 $11.90 $16.36 -11.11%
December, 2028 $12.30 $11.46 $13.04 -10.87%

Avita Medical Inc Stock (RCEL) Price Forecast for 2029

The 2029 price forecast for Avita Medical Inc Stock (RCEL) is $9.6661 on average, with a high prediction of $15.36 and a low estimate of $3.9768. This represents an -29.96% decrease from the previous price of $13.80.
Month Average Low High Change from today's price
January, 2029 $6.5454 $6.1654 $12.34 -52.57%
February, 2029 $7.6582 $5.5242 $8.8782 -44.51%
March, 2029 $7.6209 $6.4095 $10.07 -44.78%
April, 2029 $8.9568 $7.5241 $11.14 -35.10%
May, 2029 $13.17 $8.68 $13.73 -4.57%
June, 2029 $13.52 $11.79 $14.97 -2.01%
July, 2029 $12.13 $11.88 $15.36 -12.11%
August, 2029 $5.0909 $4.9509 $13.09 -63.11%
September, 2029 $4.7236 $4.4308 $6.1036 -65.77%
October, 2029 $4.8495 $3.9768 $6.7594 -64.86%
November, 2029 $5.8522 $4.0991 $5.9172 -57.59%
December, 2029 $6.0781 $4.0581 $7.0836 -55.96%

Avita Medical Inc Stock (RCEL) Price Forecast for 2030

Avita Medical Inc Stock (RCEL) is expected to reach an average price of $6.064 in 2030, with a high forecast of $10.75 and a low forecast of $1.3804. This signifies an -56.06% decrease from the last price of $13.80.
Month Average Low High Change from today's price
January, 2030 $5.3609 $4.7409 $6.5513 -61.15%
February, 2030 $7.2536 $5.2741 $7.5472 -47.44%
March, 2030 $6.6763 $6.275 $7.6468 -51.62%
April, 2030 $9.9022 $6.5295 $10.38 -28.24%
May, 2030 $8.345 $7.875 $10.48 -39.53%
June, 2030 $5.7277 $5.0977 $10.75 -58.50%
July, 2030 $7.1736 $4.944 $7.8536 -48.02%
August, 2030 $5.1663 $4.6731 $7.6068 -62.56%
September, 2030 $5.2522 $3.529 $6.4295 -61.94%
October, 2030 $5.885 $4.9054 $6.9318 -57.36%
November, 2030 $2.2777 $2.1177 $6.4931 -83.50%
December, 2030 $1.9636 $1.3804 $2.9909 -85.77%
$8.21
price up icon 2.43%
$9.85
price up icon 2.71%
$13.51
price up icon 5.79%
SI SI
$18.72
price up icon 2.58%
$2.31
price up icon 4.05%
$8.62
price up icon 4.36%
Cap:     |  Volume (24h):